Prof. Jan Lycke
Prof. Lycke obtained his MD at the faculty of medicine at Gothenburg University 1983 and a PhD from the Institute of Neuroscience and Physiology at the the same faculty 1993.
He became a board certified specialist in Clinical Neurology 1989. Since 2014 Jan has been a professor of neurology at the Sahlgrenska Academy, Gothenburg University and is currently head of the MS Research Centre at Sahlgrenska University Hospital, Gothenburg, Sweden. Prior to this, he was the Director of the Department of Neurology at Sahlgrenska University Hospital 1999-2001, President of the Swedish MS Association 2003-2005, and President of the Swedish Neurological Society 2004-2006. He was a Swedish delegate of the council of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2006-2010 and chaired the ECTRIMS/RIMS meeting in Gothenburg in 2010.
He is currently a member of the steering committee of the Swedish MS Registry, chairman of the board of MS therapies, Swedish MS Association, and Director of the Foundation for MS research in Sweden. He was co-author of the MS treatment guidelines by the Swedish Medical Products Agency 2015 and the chairman of evaluating the scientific basis of the first national Swedish MS guidelines for healthcare of MS published December 2016 by the National Board of Health and Welfare in Sweden. He is currently a member of the EAN Scientific Panel of MS and the ECTRIMS Council. Over two decades he has been the principal and the national investigator of numerous clinical treatment trials of MS including phase I-IV trials. He is certified for GCP and EDSS. He has published scientific papers in epidemiology, virology and immunology of MS and is currently working with projects on biological markers for characterising the immunpathogenesis of MS, monitoring disease activity and therapeutic interventions of MS.